Purchase Order 75N91020P00251
- Not listed
- This federal contract award is for a maintenance agreement on various laboratory equipment, valued at $30,087.45, awarded by the National Cancer Institute (NCI) to Bio-Rad Laboratories, Inc. Life Science Group Division. The contract has an ultimate completion date of March 31, 2025. Bio-Rad Laboratories, Inc. is the parent company of the prime contractor and has established significant Indefinite Delivery Vehicles (IDVs) and Blanket Purchase Agreements (BPAs) with various federal agencies,...
- This federal contract award is for a MAINTENANCE AGREEMENT between the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services (HHS), and Bio-Rad Laboratories, Inc. The contract has a ceiling value of $10,783.00 and a completion date of December 31, 2025. It was awarded on January 1, 2025 as a Firm Fixed Price Purchase Order. The contract does not have a set-aside designation. Bio-Rad Laboratories, Inc. is the prime contractor and is a global...
- This federal contract award, with an ID of 75N91025P00014, is a firm fixed-price purchase order for $10,783.00 awarded by the National Cancer Institute, a civilian agency of the U.S. government, to Bio-Rad Laboratories, Inc.'s Life Science Group Division. The contract is for recertification and service with a completion date of December 8, 2025. Bio-Rad Laboratories, Inc. is a global leader in life science research and clinical diagnostics equipment, reagents, and consumables. This contract does...
- This firm fixed-price purchase order contract was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Bio-Rad Laboratories, Inc. Life Science Group Division, a subsidiary of the parent company Bio-Rad Laboratories, Inc. The $18,625.40 contract is for a maintenance agreement, with a period of performance ending on April 5, 2025. Bio-Rad Laboratories, Inc. is an experienced federal contractor that has been awarded numerous contracts and...
- This federal contract award, valued at $60,690.96, was issued by the National Cancer Institute (NCI) to Bio Rad Laboratories Inc. to provide unlimited repair services for government-owned Bio-Rad laboratory equipment. The contract has a firm fixed price and is set to run through December 30, 2024. Bio Rad Laboratories Inc. is the prime contractor, and as a global manufacturer of life science research and clinical diagnostic products, the company has secured numerous federal contracts to supply...
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Bio-Rad Laboratories, Inc. Life Science Group Division, a subsidiary of Bio-Rad Laboratories, Inc. The $10,188.00 contract is for a service agreement with a completion date of May 13, 2025. The contract does not have a set-aside designation. Bio-Rad Laboratories, Inc. is an experienced federal contractor that provides a variety of...
- This is a $10,783.00 firm fixed-price service agreement awarded to Bio-Rad Laboratories, Inc., a global leader in scientific instrumentation and laboratory supplies, by the National Cancer Institute. The contract is for the delivery of unspecified products and services related to the agency's research activities, with a period of performance through April 2026. The contract is not set aside for small businesses. Bio-Rad Laboratories, Inc. holds a significant $1 billion blanket purchase agreement...
- This federal contract award is for $12,625.00 in one-time preventative maintenance services for a PCR system by Bio-Rad Laboratories, Inc. Life Science Group Division, a subsidiary of Bio-Rad Laboratories, Inc. The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services (HHS). The contract has a completion date of September 18, 2025 and was awarded on September 23, 2024 using a firm fixed price...
- Bio-Rad Laboratories, Inc. was awarded a firm fixed-price Blanket Purchase Agreement (BPA) call valued at $24,995.00 by the National Cancer Institute on March 19, 2018, with performance completion scheduled for December 31, 2018. This contract was placed at the National Cancer Institute facility in Bethesda, Maryland, and was not designated as a small business set-aside. The award represents a call against Bio-Rad's broader procurement vehicle with the National Institutes of Health, through...
- This is a firm fixed-price purchase order contract awarded by the National Cancer Institute, a component of the National Institutes of Health (NIH), to Bio-Rad Laboratories, Inc. for the provision of various Bio-Rad real-time PCR systems. The contract has a total ceiling value of $11,685.88 and a completion date of December 31, 2024. Bio-Rad Laboratories is an experienced federal contractor, having previously provided specialized equipment, reagents, and services to various government agencies...
This federal contract award, with ID 75N91020P00251, is for a maintenance agreement between the National Cancer Institute and Bio-Rad Laboratories, Inc. The $20,112.02 firm fixed-price contract does not have a set-aside designation. The contract was awarded on February 18, 2020 with an ultimate completion date of April 5, 2025. Bio-Rad Laboratories, Inc. is a global leader in developing and manufacturing products for life science research and clinical diagnostics. The company has established relationships with multiple government agencies, particularly in the health and research sectors, through prime federal contract awards, subcontracts, and grant sub-awards. This maintenance agreement is a task order under Bio-Rad's $1 billion Blanket Purchase Agreement with the National Institutes of Health Office of Logistics and Acquisition Operations, which facilitates the procurement of various laboratory supplies, materials, and services across NIH research activities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Funding Only Action | 0$ | 3/31/25 | |
| P00001 | Funding Only Action | ($1k) | 12/7/24 | |
| Not listed | Not listed | $21.2k | 2/18/20 |